Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines, Boosters & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

 

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

Florin Marian Selaru, M.D.

Headshot of Florin Marian Selaru
  • Director, Meyerhoff Inflammatory Bowel Disease Center
  • Associate Professor of Medicine
Male

Languages: English, Romanian

Expertise

Cholangiocarcinoma, Clinical Gastroenterology, Colitis, Crohn's Disease, Diarrhea, Digestive Disorders, Fecal Microbiota Transplantation, Gastroenterology, Inflammatory Bowel Disease (IBD), Proctitis, Sclerosing Cholangitis, Ulcerative Colitis ...read more

Research Interests

Cancer development and progression in the gastrointestinal tract; Molecular changes associated with the transition from inflammatory states in the GI tract (colon, stomach, biliary tree) to frank cancers ...read more

Request an Appointment

Insurance Information

Main Phone

410-933-7495

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

Johns Hopkins Gastroenterology and Hepatology - Howard County

Appointment Phone: 410-933-7495
5450 Knoll North Drive
Suite 390
Columbia, MD 21045 map

The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 410-933-7495
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287 map

Background

Dr. Selaru is currently an Associate Professor of Medicine and Oncology, Division of Gastroenterology and Hepatology and Sidney Kimmel Cancer Center, Johns Hopkins University. He is also a member of the Institute of Nanobiotechnology at Johns Hopkins University. Since its start in 2009, Dr. Selaru has also been directing his basic and applied science laboratory in cancer research at Johns Hopkins.

Dr. Selaru's focus is in bringing cutting edge molecular biology, genetics and engineering to the care of patients with gastroenterological disorders, in particular patients with GI cancers. His laboratory focuses on premalignant conditions such as colonic inflammation that can lead to colon cancer and inflammatory conditions of the hepatobiliary tract (such as primary sclerosing cholangitis or liver cirrhosis/fibrosis) that can lead to cholangiocarcinoma or hepatocellular cancer. The laboratory studies genetic alterations that can be utilized to understand disease progression from normal tissue to inflamed tissue to cancer, as well as to develop markers of early cancer. In addition, the laboratory focuses on epigenetic alterations, such as microRNA. Our recent studies demonstrated a rich, and previously unknown, intercellular communication between cancer cells and stroma, through small vesicles (exosomes) loaded with microRNA species. Last, the laboratory's focus is to bring microdevices and information technology to medicine.

Dr. Selaru's overarching goal is to deliver medical products and technologies to cancer patients, through an integrative approach that combines mathematics and data analysis, clinical gastroenterology, molecular and cell biology, engineering and business administration.

...read more

Titles

  • Director, Meyerhoff Inflammatory Bowel Disease Center
  • Associate Professor of Medicine
  • Associate Professor of Oncology

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; Carol Davila University of Medicine (1999)

Residencies

  • Internal Medicine; University of Maryland Medical Center (2006)

Fellowships

  • Gastroenterology; Johns Hopkins University School of Medicine (2009)
  • Gastroenterology and Hepatology; University of Maryland Medical Center (2007)

Board Certifications

  • American Board of Internal Medicine (Gastroenterology) (2009)

Research & Publications

Research Summary

Dr. Selaru’s research interests comprise the molecular changes associated with the transition from inflammatory states in the GI tract (colon, stomach, biliary tree) to frank cancers. In addition, Dr. Selaru’s current research funded from the AGA, FAMRI and the Broad Foundation works to further the understanding of cancer development and progression in the gastrointestinal tract.

Videos & Media

Recent News Articles and Media Coverage

Johns Hopkins Develops Tiny Machines That Deliver Medicine to the Intestines, Inside Tract (Winter, 2021)

Hopkins Researchers Deliver Gene Therapy Directly to the Liver, Inside Tract (Fall, 2018)

A Firmer Grip on Cancer Diagnosis, Inside Tract (Spring, 2015)

Is this you? Edit Profile
back to top button